Previously Funded Researchers

See researchers who have made a difference in research we have funded in previous years through our nationwide research awards, showcasing the breadth of the work and scientists we have supported.
  • Shumin Tan, Ph.D.

    Shumin Tan, Ph.D.

    Tufts University

    How Does Mycobacterium Tuberculosis Adapt to Life in Humans?

  • Shumin Tan, PhD

    Shumin Tan, PhD

    Tufts University

    Gaining Insights into a Regulator that Affects Growth of Mycobacterium tuberculosis

  • Moon-Shong Tang

    Moon-Shong Tang

    New York University School of Medicine

    Do E-Cigarettes Lead to Lung Cancer?

  • Wei Tao, PhD

    Wei Tao, PhD

    Brigham and Women's Hospital, Inc.

    Inhalation Delivery of mRNA via Targeted NPs for Lung Cancer Treatment

  • Alison Taylor, PhD

    Alison Taylor, PhD

    Columbia University

    Effect of Changes in Chromosome Number in Lung Squamous Cell Carcinoma

  • Kathryn L. Taylor, PhD

    Kathryn L. Taylor, PhD

    Georgetown University

    Testing Methods to Increase Lung Cancer Screening Among Quitline Callers

  • Steven Templeton

    Steven Templeton

    Indiana University

    Adiponectin-Mediated Inhibition of Detrimental Inflammation in Invasive Aspergillosis

  • Justine Tigno-Aranjuez

    Justine Tigno-Aranjuez

    University of Central Florida

    Negative Regulation of Allergic Asthma by LMAN1, a Novel Receptor for House Dust Mite

  • Trent Tipple, MD

    Trent Tipple, MD

    University of Oklahoma, Health Sciences Center

    Determing Selenium’s Role in Bronchopulmonary Dysplasia

  • Lara Traeger, PhD

    Lara Traeger, PhD

    Massachusetts General Hospital

    Addressing Needs of Lung Cancer Patients Facing Risk of Recurrence

  • Phuoc Tran, M.D., Ph.D.

    Phuoc Tran, M.D., Ph.D.

    Johns Hopkins University

    Targeting a Gene Involved in Lung Cancer Drug Resistance

  • Matthew Triplette, MD, MPH, BA

    Matthew Triplette, MD, MPH, BA

    Fred Hutchinson Cancer Research Center

    Assisting in Smoking Cessation and Lung Cancer Screening in Indigenous People in SeaTle (ASSIST)

  • MuChun Tsai, MD

    MuChun Tsai, MD

    Ohio State University Office of Sponsored Programs

    MARCH10 Effects on Cilia During Influenza Infection

  • Alexei Tumanov, M.D., Ph.D.

    Alexei Tumanov, M.D., Ph.D.

    Columbia University

    Investigating Origins of Idiopathic Pulmonary Fibrosis Development

  • Argyrios Tzouvelekis, Ph.D.

    Argyrios Tzouvelekis, Ph.D.

    Yale University

    Enzyme Could Play Key Role in Idiopathic Pulmonary Fibrosis

  • Johanna Uthoff

    Johanna Uthoff

    University of Iowa

    Lung Cancer Risk Assessment Using Quantitative Imaging

  • Anna Volerman, MD

    Anna Volerman, MD

    University of Chicago

    Evaluating Asthma Management Policy in Chicago Schools

  • Narendra Wajapeyee, Ph.D.

    Narendra Wajapeyee, Ph.D.

    Yale University

    Targeting p53 Gene to Treat Lung Cancer

  • Guanghu Wang, Ph.D.

    Guanghu Wang, Ph.D.

    Georgia Regents University

    Fighting Drug Resistance in Lung Cancer

  • Jing Gennie Wang, MD

    Jing Gennie Wang, MD

    Ohio State University

    Determining Influence of Plant-Based Diet on Asthma and Response to Air Pollution

  • Yanzhuang Wang, PhD

    Yanzhuang Wang, PhD

    The Regents of the University of Michigan

    SARS-CoV-2 Modulates the Golgi Structure to Facilitate Viral Trafficking

  • Jeffrey P. Ward, MD, PhD

    Jeffrey P. Ward, MD, PhD

    Washington University School of Medicine

    Personalized Neoantigen Vaccine and Durvalumab in ES-SCLC

  • Noel Warfel, Ph.D.

    Noel Warfel, Ph.D.

    University of Arizona

    Blocking Enzyme PIM Kinase to Treat Non-Small Cell Lung Cancer

  • Hideo Watanabe, M.D., Ph.D.

    Hideo Watanabe, M.D., Ph.D.

    Icahn School of Medicine at Mount Sinai

    Understanding the Complexity and Variability of Lung Tumors

  • Hideo Watanabe, MD, PhD

    Hideo Watanabe, MD, PhD

    Icahn School of Medicine at Mount Sinai

    Distinguishing Different Subgroups of Lung Cancer to Improve Treatment

  • Pamela Wearsch, Ph.D.

    Pamela Wearsch, Ph.D.

    Case Western Reserve University - School of Medicine

    Particles in TB Membrane Could be Target for Treatment

  • Nathaniel Weathington, M.D., Ph.D.

    Nathaniel Weathington, M.D., Ph.D.

    University of Pittsburgh

    Testing New Drug Therapies for Acute Respiratory Distress Syndrome Using Donor Lungs

  • Kipp Weiskopf, MD, PhD

    Kipp Weiskopf, MD, PhD

    Whitehead Institute for Biomedical Research

    Discovering More Effective Ways to Treat KRAS Mutant Lung Cancer

  • Gary A. Weisman, PhD

    Gary A. Weisman, PhD

    The Curators of the University of Missouri

    P2Y2 receptor-integrin interactions in Spike- and ACE2-mediated SARS-CoV-2 entry in lung alveolar epithelial cells

  • Daniel Weiss, MD, PhD

    Daniel Weiss, MD, PhD

    The University of Vermont State and Agricultural College

    Mechanisms of SARS-CoV-2 induced type 2 alveolar epithelial cell pathogenesis

Next
Fight For Air Climb - Cleveland, OH
Cleveland, OH | Mar 01, 2026
Fight For Air Climb - Columbus, OH
Columbus, OH | Mar 22, 2026